array(3) { ["company_details"]=> array(13) { ["name"]=> string(28) "Bristol-Myers Squibb Company" ["slug"]=> string(37) "81631-us-bristol-myers-squibb-company" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/7b41874f-2658-484b-890c-9b9bd5a41f13" ["description"]=> string(1400) "At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html" ["address_street"]=> string(19) "430 E 29TH St FL 14" ["address_place"]=> string(8) "New York" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1887-02-28" ["website_domain"]=> string(7) "bms.com" ["website_url"]=> string(19) "https://www.bms.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(1200) ["article_count"]=> int(2495) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(54) "Bristol-Myers Squibb (NYSE:BMY) Shrugs off Analyst Cut" ["snippet_en"]=> string(171) "An analyst’s cut can be an unkind one for stocks, but for healthcare stock Bristol-Myers Squibb (NYSE:BMY), it wasn’t nearly as bad as it might have been. In fact, ..." ["url"]=> string(81) "https://www.tipranks.com/news/bristol-myers-squibb-nysebmy-shrugs-off-analyst-cut" ["image_url"]=> NULL ["source"]=> string(12) "tipranks.com" ["publication_date"]=> string(10) "2024-03-11" ["categories"]=> array(4) { [0]=> string(22) "Sustainable Investment" [1]=> string(24) "Stock Research & Ratings" [2]=> string(12) "Stock Market" [3]=> string(12) "Board Change" } } [1]=> array(7) { ["title_en"]=> string(60) "The 3 Best Stocks Beginning Investors Can Buy: February 2024" ["snippet_en"]=> string(129) "Starting your investment journey? Navigate the market with confidence! Discover 3 stocks for beginning investors in this article." ["url"]=> string(94) "https://investorplace.com/2024/02/the-3-best-stocks-beginning-investors-can-buy-february-2024/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/83918bdc-ad3e-437b-8102-171f3e499100" ["source"]=> string(17) "investorplace.com" ["publication_date"]=> string(10) "2024-02-21" ["categories"]=> array(11) { [0]=> string(25) "Business Model Resilience" [1]=> string(18) "General Investment" [2]=> string(24) "Stock Research & Ratings" [3]=> string(18) "Financial Distress" [4]=> string(9) "Investors" [5]=> string(24) "Quarterly/Annual Figures" [6]=> string(31) "Financial Update/Profit Warning" [7]=> string(15) "Market Movement" [8]=> string(12) "Stock Market" [9]=> string(18) "Expansion & Growth" [10]=> string(19) "Investment Requests" } } [2]=> array(7) { ["title_en"]=> string(80) "Bristol-Myers Squibb (NYSE:BMY) - Stock Price, News & Analysis - Simply Wall St" ["snippet_en"]=> string(163) "Research Bristol-Myers Squibb's (NYSE:BMY) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more." ["url"]=> string(85) "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bmy/bristol-myers-squibb" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4de830b8-96f1-41ad-9b3a-d3f1302099c4" ["source"]=> string(13) "simplywall.st" ["publication_date"]=> string(10) "2024-02-18" ["categories"]=> array(5) { [0]=> string(12) "Stock Market" [1]=> string(24) "Stock Research & Ratings" [2]=> string(21) "Shareholders Feedback" [3]=> string(15) "Market Movement" [4]=> string(11) "Acquisition" } } [3]=> array(7) { ["title_en"]=> string(56) "Analyst: Positive Catalysts Can't Save This Pharma Stock" ["snippet_en"]=> string(85) "Bristol-Myers Squibb (BMY) was downgraded to "neutral" from "buy" by Redburn-Atlantic" ["url"]=> string(113) "https://www.schaeffersresearch.com/content/news/2024/02/06/analyst-positive-catalysts-cant-save-this-pharma-stock" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8bc42518-41cc-43ed-84cc-8d8f8bc935e0" ["source"]=> string(22) "schaeffersresearch.com" ["publication_date"]=> string(10) "2024-02-06" ["categories"]=> array(3) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(19) "Economic Conditions" [2]=> string(12) "Stock Market" } } [4]=> array(7) { ["title_en"]=> string(84) "Bristol-Myers Squibb Company Share Price Target '$60.38', now 16.8% Upside Potential" ["snippet_en"]=> string(84) "Bristol-Myers Squibb Company Share Price Target '$60.38', now 16.8% Upside Potential" ["url"]=> string(130) "https://www.directorstalkinterviews.com/bristol-myers-squibb-company-share-price-target-60.38-now-16.8-upside-potential/4121137557" ["image_url"]=> string(78) "https://images.businessradar.com/articles/b3648a62-8451-4157-bc26-39060e259805" ["source"]=> string(27) "directorstalkinterviews.com" ["publication_date"]=> string(10) "2024-01-05" ["categories"]=> array(3) { [0]=> string(15) "Market Movement" [1]=> string(24) "Stock Research & Ratings" [2]=> string(12) "Stock Market" } } [5]=> array(7) { ["title_en"]=> string(55) "3 Dividend Stocks for Strong Returns in 2024 and Beyond" ["snippet_en"]=> string(118) "Investors should consider these three dividend stocks for 2024 and beyond, as they offer compelling yields and safety." ["url"]=> string(90) "https://investorplace.com/2024/01/3-dividend-stocks-for-strong-returns-in-2024-and-beyond/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/bd7c478e-e4a8-495b-9ee4-b734cbeecd49" ["source"]=> string(17) "investorplace.com" ["publication_date"]=> string(10) "2024-01-04" ["categories"]=> array(5) { [0]=> string(18) "General Investment" [1]=> string(12) "Stock Market" [2]=> string(24) "Stock Research & Ratings" [3]=> string(9) "Investors" [4]=> string(19) "Economic Conditions" } } [6]=> array(7) { ["title_en"]=> string(90) "Cantor Fitzgerald slashes price target on Bristol-Myers Squibb Co. [BMY] – find out why." ["snippet_en"]=> string(99) "Bristol-Myers Squibb Co.[ NYSE: BMY] stock went on a downward path that fall over -1.13% on Friday," ["url"]=> string(114) "https://dbtnews.com/2023/12/18/cantor-fitzgerald-slashes-price-target-on-bristol-myers-squibb-co-bmy-find-out-why/" ["image_url"]=> NULL ["source"]=> string(11) "dbtnews.com" ["publication_date"]=> string(10) "2023-12-18" ["categories"]=> array(2) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Stock Market" } } [7]=> array(7) { ["title_en"]=> string(65) "Exelixis, Inc. - Consensus 'buy' rating and 9.5% Upside Potential" ["snippet_en"]=> string(65) "Exelixis, Inc. - Consensus 'buy' rating and 9.5% Upside Potential" ["url"]=> string(109) "https://www.directorstalkinterviews.com/exelixis-inc.consensus-buy-rating-and-9.5-upside-potential/4121136225" ["image_url"]=> string(78) "https://images.businessradar.com/articles/19c08289-7708-470f-9939-cfdeac1e5d99" ["source"]=> string(27) "directorstalkinterviews.com" ["publication_date"]=> string(10) "2023-12-15" ["categories"]=> array(1) { [0]=> string(24) "Stock Research & Ratings" } } [8]=> array(7) { ["title_en"]=> string(63) "Could Bristol-Myers Squibb Stock Help You Retire A Millionaire?" ["snippet_en"]=> string(86) "It isn't exactly a growth stock, but it has a few features that could make you richer." ["url"]=> string(93) "https://www.fool.com/investing/2023/11/16/could-bristol-myers-squibb-stock-help-you-retire-a/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/eeaa6f60-86fc-44bf-ba17-e7556ad45a9e" ["source"]=> string(8) "fool.com" ["publication_date"]=> string(10) "2023-11-16" ["categories"]=> array(2) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(12) "Stock Market" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(254) } [1]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(163) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(151) } [3]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(94) } [4]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(89) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(76) } [6]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(74) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(64) } [8]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(63) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(60) } [10]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(60) } [11]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(56) } [12]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(54) } [13]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(47) } [14]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(47) } [15]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(45) } [16]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(45) } [17]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(42) } [18]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(39) } [19]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(35) } [20]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(35) } [21]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(33) } [22]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(32) } [23]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(28) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(27) } [25]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [26]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(24) } [27]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(22) } [28]=> array(2) { ["name"]=> string(9) "Valuation" ["count"]=> int(21) } [29]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(21) } } } 81631-us-bristol-myers-squibb-company